0.4652
price down icon9.07%   -0.0464
after-market Handel nachbörslich: .48 0.0148 +3.18%
loading

Finanzdaten der Applied Therapeutics Inc-Aktie (APLT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- 0.122 0.144 0.19
Operating Expenses
22.70%
25.52
33.02 29.86 20.58 21.28
Operating Income/Loss
22.70%
-25.52
-33.02 -29.74 -20.44 -21.09
Nonoperating Income/Loss
95.20%
3.70
77.03 -38.85 23.34 -62.84
Income/Loss From Continuing Operations Before Tax
149.59%
-21.82
44.01 0.122 2.898 -83.94
Income/Loss From Continuing Operations After Tax
149.59%
-21.82
44.01 -68.59 2.898 -83.94
Net Income/Loss
149.59%
-21.82
44.01 -68.59 2.898 -83.94
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
8,720%
144.79
1.6415 144.35 143.93 125.32
Diluted Average Shares
8,720%
144.79
1.6415 144.35 152.39 125.32
Basic Earnings Per Share
145.45%
-0.15
0.33 -0.48 0.02 -0.67
Diluted Earnings Per Share
145.45%
-0.15
0.33 -0.48 -0.13 -0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):